Studies from New York University (NYU) in the Area of Lung Cancer Reported (Glutamine Antagonist Drp-104 Suppresses Tumor Growth and Enhances Response To Checkpoint Blockade In keap1 Mutant Lung Cancer)

Source :: Obesity, Fitness & Wellness Week. May 4, 2024, 1903
Publication Year :: 2024
Abstract: 2024 MAY 4 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Oncology - Lung Cancer have been published. According [...]

Subjects :: Gene mutations -- Health aspects
Tumor suppressor genes -- Analysis
Lung cancer -- Prognosis -- Care and treatment -- Genetic aspects
Xenotransplantation -- Patient outcomes
Health

Tools